{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:33:52Z","timestamp":1791304432105,"version":"4.3.1"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["AID-OAA-A-15-00035"],"award-info":[{"award-number":["AID-OAA-A-15-00035"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009054","name":"U.S. President\u2019s Emergency Plan for AIDS Relief","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012386","name":"Magee-Womens Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.contraception.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T08:22:37Z","timestamp":1633940557000},"page":"16-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0839-2830","authenticated-orcid":false,"given":"Kathleen","family":"Ridgeway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5477-4445","authenticated-orcid":false,"given":"Elizabeth T.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-194X","authenticated-orcid":false,"given":"Kevin","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Torjesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"van der Straten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7478-8262","authenticated-orcid":false,"given":"Sharon L.","family":"Achilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4621-2773","authenticated-orcid":false,"given":"Jennifer B.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0001","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.antiviral.2010.09.003","article-title":"Advances in microbicide vaginal rings","volume":"88","author":"Malcolm","year":"2010","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/humrep\/16.3.469","article-title":"Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol","volume":"16","author":"Roumen","year":"2001","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0003","first-page":"823","article-title":"Efficacy and tolerability of a novel estradiol vaginal ring for relief of menopausal symptoms","volume":"102","author":"Speroff","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.10.001_bib0004","series-title":"IPM\u2019s Dapivirine Ring for Women\u2019s HIV Prevention Receives WHO Prequalification [press release]","year":"2020"},{"key":"10.1016\/j.contraception.2021.10.001_bib0005","series-title":"WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection [press release]","year":"2021"},{"key":"10.1016\/j.contraception.2021.10.001_bib0006","series-title":"IPM Welcomes WHO\u2019s Recommendation for Dapivirine Vaginal Ring as New Women\u2019s HIV Prevention Option [press release]","year":"2021"},{"key":"10.1016\/j.contraception.2021.10.001_bib0007","series-title":"Vaginal ring to reduce the risk of HIV infection for women in non-EU countries with high disease burden [press release]","year":"2020"},{"key":"10.1016\/j.contraception.2021.10.001_bib0008","series-title":"#BREAKING: Dapivirine, Vaginal Ring Approved for Use in Zimbabwe","author":"Gwarisa","year":"2021"},{"key":"10.1016\/j.contraception.2021.10.001_bib0009","series-title":"IPM\u2019s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration [press release]","year":"2021"},{"issue":"22","key":"10.1016\/j.contraception.2021.10.001_bib0010","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women","volume":"375","author":"Baeten","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2021.10.001_bib0011","series-title":"About the Dapivirine Ring New York City","year":"2021"},{"key":"10.1016\/j.contraception.2021.10.001_bib0012","series-title":"HIV Research for Prevention conference; 21-25 October, 2018; Madrid","first-page":"46","article-title":"Safety and Pharmacokinetics of Dapivirine and Levonorgestrel Vaginal Rings for Multipurpose Prevention of HIV and Pregnancy","author":"Achilles","year":"2018"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0013","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/S2214-109X(18)30029-9","article-title":"Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model","volume":"6","author":"Bearak","year":"2018","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.contraception.2021.10.001_bib0014","series-title":"Women and Girls and HIV","year":"2018"},{"key":"10.1016\/j.contraception.2021.10.001_bib0015","unstructured":"Trends in maternal mortality 2000 to 2017: estimates by WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. 2017."},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0016","doi-asserted-by":"crossref","first-page":"203","DOI":"10.9745\/GHSP-D-13-00010","article-title":"Use of modern contraception increases when more methods become available: analysis of evidence from 1982-2009","volume":"1","author":"Ross","year":"2013","journal-title":"Glob Health Sci Pract"},{"issue":"11","key":"10.1016\/j.contraception.2021.10.001_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224898","article-title":"Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis","volume":"14","author":"Griffin","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0018","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1363\/psrh.12103","article-title":"A Qualitative Systematic Review of Women's Experiences Using Contraceptive Vaginal Rings: Implications for New Technologies","volume":"51","author":"Vargas","year":"2019","journal-title":"Perspect Sex Reprod Health"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0020","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.contraception.2021.10.001_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.contraception.2021.10.001_bib0022","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0023","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10461-007-9266-z","article-title":"Assessing microbicide acceptability: a comprehensive and integrated approach","volume":"12","author":"Morrow","year":"2008","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0024","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"issue":"7414","key":"10.1016\/j.contraception.2021.10.001_bib0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2021.10.001_bib0026","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1536867X0800800403","article-title":"Meta-regression in Stata","volume":"8","author":"Harbord","year":"2008","journal-title":"Stata J"},{"issue":"7109","key":"10.1016\/j.contraception.2021.10.001_bib0027","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0028","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2352-3018(20)30304-0","article-title":"Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study","volume":"8","author":"Baeten","year":"2021","journal-title":"Lancet HIV"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0029","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2020.05.004","article-title":"Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate","volume":"102","author":"Chen","year":"2020","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0030","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.contraception.2006.10.009","article-title":"Bleeding patterns of women using extended regimens of the contraceptive vaginal ring","volume":"75","author":"Barreiros","year":"2007","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0031","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10461-019-02457-0","article-title":"A Mixed-Methods Study Examining Adherence to and Acceptability of Intravaginal Rings for HIV Prevention: Behavioral Results of MTN-027","volume":"24","author":"Bauermeister","year":"2020","journal-title":"AIDS Behav"},{"key":"10.1016\/j.contraception.2021.10.001_bib0032","first-page":"115","article-title":"Safety and acceptability trial of the dapivirine vaginal ring in US adolescents","volume":"20","author":"Bunge","year":"2017","journal-title":"J Int Aids Soc"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0033","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/13625187.2014.914488","article-title":"Quality of sexual life of women using the contraceptive vaginal ring in extended cycles: preliminary report","volume":"19","author":"Caruso","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0034","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s001920050040","article-title":"Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group","volume":"10","author":"Casper","year":"1999","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0010-7824(98)00043-2","article-title":"The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women","volume":"57","author":"Chen","year":"1998","journal-title":"Contraception"},{"issue":"13","key":"10.1016\/j.contraception.2021.10.001_bib0036","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2217\/cer-2019-0091","article-title":"Ospemifene versus local estrogen: adherence and costs in postmenopausal dyspareunia","volume":"8","author":"Faught","year":"2019","journal-title":"J Comp Eff Res"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0037","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/13625187.2016.1234598","article-title":"Discontinuation of modern hormonal contraceptives: an Italian survey","volume":"21","author":"Fruzzetti","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0038","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/gme.0b013e318148b98b","article-title":"The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status","volume":"15","author":"Gupta","year":"2008","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0039","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1089\/jwh.2011.2967","article-title":"Continuation rate of combined hormonal contraception: a prospective multicenter study","volume":"21","author":"Lete","year":"2012","journal-title":"J Women's Health"},{"issue":"9","key":"10.1016\/j.contraception.2021.10.001_bib0040","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/humrep\/del162","article-title":"Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone","volume":"21","author":"Milsom","year":"2006","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0041","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/humrep\/deh604","article-title":"Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial","volume":"20","author":"Oddsson","year":"2005","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0042","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0b013e31820563d3","article-title":"One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives","volume":"117","author":"Raine","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0043","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2006.03.022","article-title":"Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives","volume":"74","author":"Sabatini","year":"2006","journal-title":"Contraception"},{"issue":"4-6","key":"10.1016\/j.contraception.2021.10.001_bib0044","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0960-0760(91)90294-F","article-title":"Contraception with progestogens and progesterone during lactation","volume":"40","author":"Shaaban","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0045","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0010-7824(81)90003-2","article-title":"A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. I-Use effectiveness. An international comparative trial","volume":"24","author":"Sivin","year":"1981","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0046","doi-asserted-by":"crossref","first-page":"e25094","DOI":"10.1002\/jia2.25094","article-title":"The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention","volume":"21","author":"van der Straten","year":"2018","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0047","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.AOG.0000164483.13326.59","article-title":"Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive","volume":"106","author":"Westhoff","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0048","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ajog.2015.08.001","article-title":"Three-year continuation of reversible contraception","volume":"213","author":"Diedrich","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.contraception.2021.10.001_bib0049","first-page":"424","article-title":"Factors influencing women's preference to select a combined hormonal contraceptive method: a cross-sectional survey in Lithuania","volume":"48","author":"Cepuliene","year":"2012","journal-title":"Medicina (B Aires)"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/13625187.2014.980501","article-title":"Women's experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal","volume":"20","author":"Palmeira-de-Oliveira","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0051","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2006.07.004","article-title":"Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone","volume":"74","author":"Ahrendt","year":"2006","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0052","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.GME.0000163870.03388.4D","article-title":"Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetate","volume":"12","author":"Al-Azzawi","year":"2005","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0053","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-5122(96)01087-0","article-title":"Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses","volume":"26","author":"Antoniou","year":"1997","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0054","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(96)02612-7","article-title":"Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy","volume":"71","author":"Barentsen","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13625180701577122","article-title":"Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany","volume":"13","author":"Brucker","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"8","key":"10.1016\/j.contraception.2021.10.001_bib0056","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1471-0528.2003.02408.x","article-title":"The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women","volume":"110","author":"Buckler","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0057","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3109\/13625187.2014.945164","article-title":"Contraceptive counselling and self-prescription of contraceptives of German gynaecologists: results of a nationwide survey","volume":"19","author":"Buhling","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0058","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0002-9378(94)90074-4","article-title":"A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy","volume":"171","author":"Henriksson","year":"1994","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0059","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9378(96)70378-2","article-title":"A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging","volume":"174","author":"Henriksson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.contraception.2021.10.001_bib0060","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1471-0528.2000.tb10408.x","article-title":"Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms","volume":"107","author":"Lose","year":"2000","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0061","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/13625180701440180","article-title":"Clinical experience with NuvaRing in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages","volume":"12","author":"Merki-Feld","year":"2007","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0062","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/13625187.2010.524717","article-title":"Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use","volume":"15","author":"Merki-Feld","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"10","key":"10.1016\/j.contraception.2021.10.001_bib0063","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/QAD.0000000000000280","article-title":"A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women","volume":"28","author":"Nel","year":"2014","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0064","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0010-7824(90)90103-3","article-title":"The clinical acceptability of a non-medicated vaginal ring","volume":"42","author":"Roumen","year":"1990","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/13625180500389547","article-title":"The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands","volume":"11","author":"Roumen","year":"2006","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0066","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0010-7824(98)00145-0","article-title":"Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring","volume":"59","author":"Roumen","year":"1999","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0067","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1006748626008","article-title":"Initial UK experience of the levonorgestrel-releasing contraceptive intravaginal ring","volume":"15","author":"Sahota","year":"1999","journal-title":"Adv Contracept"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0068","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1783\/147118909787931780","article-title":"Contraceptive choice for young people","volume":"35","author":"Say","year":"2009","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0069","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0378-5122(93)90059-Q","article-title":"Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy","volume":"16","author":"Smith","year":"1993","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3109\/13697139909025574","article-title":"Patient acceptability of and tolerance to a placebo intravaginal ring in hysterectomized women: a pilot study","volume":"2","author":"Spencer","year":"1999","journal-title":"Climacteric"},{"issue":"7","key":"10.1016\/j.contraception.2021.10.001_bib0071","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.fertnstert.2009.01.071","article-title":"Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis","volume":"93","author":"Vercellini","year":"2010","journal-title":"Fertil Sterilil"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0072","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/13625187.2017.1413179","article-title":"Pharmacokinetic bioequivalence, safety and acceptability of Ornibel((R)), a new polymer composition contraceptive vaginal ring (etonogestrel\/ethinylestradiol 11.00\/3.474 mg) compared with Nuvaring((R)) (etonogestrel\/ethinylestradiol 11.7\/2.7 mg)","volume":"22","author":"Algorta","year":"2017","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0073","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1471-0528.1996.tb09741.x","article-title":"A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy","volume":"103","author":"Ayton","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0074","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1068-607X(97)00001-2","article-title":"A comparative study of a low-dose estradiol vaginal ring and conjugated estrogen cream for postmenopausal urogenital atrophy","volume":"4","author":"Bachmann","year":"1997","journal-title":"Primary Care Update for OB\/GYNS"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/QAI.0000000000002244","article-title":"Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women","volume":"83","author":"Bunge","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0076","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jadohealth.2005.11.109","article-title":"33: Female adolescent's knowledge, attitudes, and perceived barriers to the vaginal contraceptive ring: Early results","volume":"38","author":"Carey","year":"2006","journal-title":"J Adolesc Health"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0077","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.07.013","article-title":"The contraceptive vaginal ring: female adolescents' knowledge, attitudes and plans for use","volume":"76","author":"Carey","year":"2007","journal-title":"Contraception"},{"issue":"7","key":"10.1016\/j.contraception.2021.10.001_bib0078","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cid\/ciy654","article-title":"Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women","volume":"68","author":"Chen","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0079","first-page":"157","article-title":"An open-label, randomized, multi-center trial to evaluate continuation rates, side effects and acceptability of the contraceptive ring vs. the contraceptive patch in women previously using combined oral contraceptives","volume":"76","author":"Creinin","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.contraception.2010.04.003","article-title":"Vaginal estrogen supplementation during Depo-Provera initiation: a randomized controlled trial","volume":"82","author":"Dempsey","year":"2010","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0081","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0010-7824(81)90006-8","article-title":"Acceptability of the contraceptive vaginal ring by rural and urban population in two Latin American countries","volume":"24","author":"Faundes","year":"1981","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0082","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.contraception.2007.01.009","article-title":"Safety and acceptability with the use of a contraceptive vaginal ring after surgical or medical abortion","volume":"75","author":"Fine","year":"2007","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0083","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.contraception.2007.03.009","article-title":"Factors associated with willingness to use the contraceptive vaginal ring","volume":"76","author":"Gilliam","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0084","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/AOG.0b013e3181cf45dc","article-title":"Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial","volume":"115","author":"Gilliam","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0085","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.fertnstert.2018.07.014","article-title":"Patient experience in a randomized trial of a weekly progesterone vaginal ring versus a daily progesterone gel for luteal support after in vitro fertilization","volume":"110","author":"Ginsburg","year":"2018","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0086","first-page":"580","article-title":"Evaluation of acceptance and satisfaction with the use of a vaginal ring delivery system in postmenopausal women","volume":"10","author":"Haney","year":"2003","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0087","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.contraception.2007.04.013","article-title":"Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences","volume":"76","author":"Hardy","year":"2007","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0088","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/jwh.2018.7001","article-title":"Preferred Product Attributes of Potential Multipurpose Prevention Technologies for Unintended Pregnancy and Sexually Transmitted Infections or HIV Among U.S. Women","volume":"28","author":"Hynes","year":"2019","journal-title":"J Women's Health"},{"issue":"8","key":"10.1016\/j.contraception.2021.10.001_bib0089","doi-asserted-by":"crossref","first-page":"e498","DOI":"10.1016\/S2352-3018(19)30145-6","article-title":"Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial","volume":"6","author":"Keller","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.contraception.2021.10.001_bib0090","series-title":"28th Annual Meeting of The North American Menopause Society October 11-14, 2017","first-page":"1418","volume":"24","author":"Leonard-Segal","year":"2017"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0091","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.fertnstert.2011.06.073","article-title":"A randomized controlled trial of NuvaRing versus combined oral contraceptive pills for pretreatment in in vitro fertilization cycles","volume":"96","author":"Liu","year":"2011","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0092","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1701-2163(16)34853-8","article-title":"Adolescents' willingness to use the contraceptive vaginal ring","volume":"33","author":"Maheux-Lacroix","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2021.10.001_bib0093","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/0378-5122(95)00963-9","article-title":"Clinical trial of the estradiol vaginal ring in the U.S","volume":"22","author":"Nachtigall","year":"1995","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0094","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0378-5122(96)01072-9","article-title":"Estradiol delivery by vaginal rings: potential for hormone replacement therapy","volume":"26","author":"Nash","year":"1997","journal-title":"Maturitas"},{"issue":"9","key":"10.1016\/j.contraception.2021.10.001_bib0095","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/gme.0b013e3182104977","article-title":"Randomized trial of estradiol vaginal ring versus oral oxybutynin for the treatment of overactive bladder","volume":"18","author":"Nelken","year":"2011","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0096","first-page":"117","article-title":"Knowledge and choices of postpartum contraception among pregnant teens","volume":"33","author":"Ortiz-Gonzalez","year":"2014","journal-title":"P R Health Sci J"},{"issue":"11","key":"10.1016\/j.contraception.2021.10.001_bib0097","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/09540121.2017.1300628","article-title":"Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city","volume":"29","author":"Peitzmeier","year":"2017","journal-title":"AIDS Care"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0098","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.contraception.2005.11.003","article-title":"Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive","volume":"73","author":"Schafer","year":"2006","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0099","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jpag.2007.06.001","article-title":"Adolescent and young women's experience with the vaginal ring and oral contraceptive pills","volume":"20","author":"Stewart","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpag.2011.02.003","article-title":"Acceptability of the vaginal contraceptive ring among adolescent women","volume":"24","author":"Terrell","year":"2011","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"E-1","key":"10.1016\/j.contraception.2021.10.001_bib0101","first-page":"370","article-title":"Adherence and acceptability of a dapivirine vaginal ring in postmenopausal us women","volume":"24","author":"van der Straten","year":"2016","journal-title":"Topics Antiviral Med"},{"issue":"11","key":"10.1016\/j.contraception.2021.10.001_bib0102","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1007\/s10461-016-1299-8","article-title":"Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States","volume":"20","author":"van der Straten","year":"2016","journal-title":"AIDS Behav"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0103","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.AOG.0000136082.59644.13","article-title":"A comparison between the vaginal ring and oral contraceptives","volume":"104","author":"Veres","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.contraception.2021.10.001_bib0104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002655","article-title":"Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial","volume":"15","author":"Vincent","year":"2018","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":"Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet","volume":"8","author":"Weisberg","year":"2005","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0106","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(99)00036-0","article-title":"A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol","volume":"59","author":"Weisberg","year":"1999","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0107","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13625187.2021.1884219","article-title":"Single-dose pharmacokinetics and pharmacodynamics assessment of oestriol and trimegestone containing vaginal rings in healthy women with childbearing potential","volume":"26","author":"de Jesus Antunes","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0108","first-page":"43","article-title":"Phase 1 PK, safety, and acceptability study of 3-month dapivirine vaginal rings","volume":"29","author":"Liu","year":"2021","journal-title":"Topics Antiviral Med"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0109","doi-asserted-by":"crossref","first-page":"e25747","DOI":"10.1002\/jia2.25747","article-title":"Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States","volume":"24","author":"Liu","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"7","key":"10.1016\/j.contraception.2021.10.001_bib0110","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/cid\/ciy652","article-title":"Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048","volume":"68","author":"Liu","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0111","doi-asserted-by":"crossref","first-page":"e01918","DOI":"10.1128\/AAC.01930-18","article-title":"Pharmacokinetics of dapivirine transfer into blood plasma, breast milk, and cervicovaginal fluid of lactating women using the dapivirine vaginal ring","volume":"63","author":"Noguchi","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.contraception.2021.10.001_bib0112","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/OLQ.0000000000001254","article-title":"Acceptability of a Tenofovir Disoproxil Fumarate Intravaginal Ring for HIV Pre-Exposure Prophylaxis Among Sexually Active Women","volume":"47","author":"Dobkin","year":"2020","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0113","first-page":"e25659","article-title":"4th HIV Research for Prevention conference (HIVR4P \/\/Virtual), 27 & 28 January 3 & 4 February 2021","volume":"24","author":"Tolley","year":"2021","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0114","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/01443615.2015.1024210","article-title":"Comparison of combined hormonal vaginal ring with ultralow-dose combined oral contraceptive pills in the management of heavy menstrual bleeding: A pilot study","volume":"36","author":"Agarwal","year":"2016","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01849492","article-title":"Contraceptive vaginal ring\u2013a rising star on the contraceptive horizon","volume":"6","author":"Buckshee","year":"1990","journal-title":"Adv Contracept"},{"key":"10.1016\/j.contraception.2021.10.001_bib0116","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejogrb.2016.05.009","article-title":"Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding","volume":"203","author":"Dahiya","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0117","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5958\/0976-5506.2016.00012.7","article-title":"Combined Contraceptive Vaginal Ring-its Acceptability in Indian Women","volume":"7","author":"Das","year":"2016","journal-title":"Indian J Public Health Res Dev"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0118","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/13625187.2016.1186269","article-title":"Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial","volume":"21","author":"Fan","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2021.10.001_bib0119","first-page":"321","article-title":"Clinical performance with contraceptive vaginal rings containing levonorgestrel","volume":"84","author":"Gupta","year":"1986","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/gye.17.3.247.254","article-title":"Estradiol\/progesterone-releasing vaginal rings for hormone replacement therapy in postmenopausal women","volume":"17","author":"Hamada","year":"2003","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0121","first-page":"QC21","article-title":"A Randomised Controlled Trial Comparing the Efficacy and Side-Effects of Intravaginal Ring (Nuvaring((R))) With Combined Oral Hormonal Preparation in Dysfunctional Uterine Bleeding","volume":"10","author":"Jain","year":"2016","journal-title":"J Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0122","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0010-7824(86)90022-3","article-title":"Bioavailability of levonorgestrel from intravaginal rings in women of low income groups","volume":"33","author":"Madhavan Nair","year":"1986","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0123","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0010-7824(81)90046-9","article-title":"Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and D-norgestrel","volume":"23","author":"Mehta","year":"1981","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0124","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s13224-014-0559-7","article-title":"Multicenter study of contraceptive vaginal ring (NuvaRing((R))) in normal daily practice in Indian women","volume":"64","author":"Pandit","year":"2014","journal-title":"J Obstet Gynecol India"},{"key":"10.1016\/j.contraception.2021.10.001_bib0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejogrb.2016.10.026","article-title":"Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial","volume":"207","author":"Priya","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0126","article-title":"Comparison of efficacy, compliance, acceptability and tolerability of hormonal contraceptive vaginal ring (NuvaRing) versus combined oral contraceptives (COCs) - a prospective randomized controlled study in a district level hospital in East Delhi","volume":"7","author":"Sharma","year":"2018","journal-title":"Int J Sci Res"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0127","first-page":"235","article-title":"Acceptability, tolerability, and satisfaction of a contraceptive vaginal ring (the NuvaRing) among Thai women","volume":"10","author":"Santibenchakul","year":"2016","journal-title":"Asian Biomed"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s13224-013-0391-5","article-title":"Efficacy, user acceptability, tolerability, and cycle control of a combined contraceptive vaginal ring: the Indian perspective","volume":"63","author":"Soni","year":"2013","journal-title":"J Obstet Gynecol India"},{"key":"10.1016\/j.contraception.2021.10.001_bib0129","first-page":"136","article-title":"Acceptablity of contraceptive vaginal ring (NuvaRing\u00ae) amongst nurses in a Malaysian Teaching Hospital","volume":"119","author":"Vijayaletchumi","year":"2012","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.contraception.2011.07.012","article-title":"Contraceptive vaginal ring treatment of heavy menstrual bleeding: a randomized controlled trial with norethisterone","volume":"85","author":"Abu Hashim","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.10.001_bib0131","series-title":"Assessing the potential of MPTs in South Africa, Uganda and Nigeria","year":"2014"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197572","article-title":"A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use","volume":"13","author":"Kestelyn","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.contraception.2021.10.001_bib0133","article-title":"Non-adherence among women enrolled in a contraceptive vaginal ring use study in Kisumu, Kenya, 2014-2015","volume":"2","author":"McLellan-Lemal","year":"2018","journal-title":"J Global Health Rep"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0134","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijgo.2011.03.008","article-title":"Combined contraceptive ring versus combined oral contraceptive (30-mug ethinylestradiol and 3-mg drospirenone)","volume":"114","author":"Mohamed","year":"2011","journal-title":"Int J Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0135","doi-asserted-by":"crossref","first-page":"e25283","DOI":"10.1002\/jia2.25283","article-title":"End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study","volume":"22","author":"Montgomery","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147743","article-title":"Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa","volume":"11","author":"Nel","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0137","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/sifp.12046","article-title":"Do women find the progesterone vaginal ring acceptable? Findings from Kenya, Nigeria, and Senegal","volume":"49","author":"RamaRao","year":"2018","journal-title":"Stud Fam Plann"},{"issue":"7","key":"10.1016\/j.contraception.2021.10.001_bib0138","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s10461-012-0215-0","article-title":"High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women","volume":"16","author":"van der Straten","year":"2012","journal-title":"AIDS Behav"},{"issue":"10","key":"10.1016\/j.contraception.2021.10.001_bib0139","doi-asserted-by":"crossref","first-page":"e25626","DOI":"10.1002\/jia2.25626","article-title":"An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose)","volume":"23","author":"Gill","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"22","key":"10.1016\/j.contraception.2021.10.001_bib0140","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women","volume":"375","author":"Nel","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0141","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2352-3018(20)30300-3","article-title":"Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study","volume":"8","author":"Nel","year":"2021","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0142","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12981-021-00343-1","article-title":"HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania","volume":"18","author":"Tubert","year":"2021","journal-title":"AIDS Res Ther"},{"issue":"8","key":"10.1016\/j.contraception.2021.10.001_bib0143","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1007\/s10461-021-03205-z","article-title":"Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial","volume":"25","author":"Mayo","year":"2021","journal-title":"AIDS Behav"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0144","first-page":"585","article-title":"Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring","volume":"100","author":"Dieben","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0010-7824(90)90141-H","article-title":"Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation","volume":"41","author":"Koetsawang","year":"1990","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0146","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0147","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0002-9378(99)70383-2","article-title":"Estradiol-delivering vaginal rings for hormone replacement therapy","volume":"181","author":"Nash","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.10.001_bib0148","series-title":"HIV Research for Prevention conference; 21-25 October, 2018; Madrid","first-page":"1","article-title":"End-User opinions about the future of HIV prevention: results from a global Internet survey about multipurpose prevention technologies (MPTs)","author":"Plagianos","year":"2018"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0149","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0010-7824(97)00008-5","article-title":"Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2004.08.010","article-title":"Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial","volume":"71","author":"Sivin","year":"2005","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0151","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.contraception.2017.12.011","article-title":"Factors associated with nonadherence to instructions for using the Nestorone(R)\/ethinyl estradiol contraceptive vaginal ring","volume":"97","author":"Stifani","year":"2018","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199778","article-title":"Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women","volume":"13","author":"Thurman","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0153","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0010-7824(99)00035-9","article-title":"Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring","volume":"59","author":"Weisberg","year":"1999","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0154","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.contraception.2004.12.014","article-title":"Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen\/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen","volume":"72","author":"Weisberg","year":"2005","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.contraception.2021.10.001_bib0155","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1007\/s10461-018-2078-5","article-title":"Young Women's Ratings of Three Placebo Multipurpose Prevention Technologies for HIV and Pregnancy Prevention in a Randomized, Cross-Over Study in Kenya and South Africa","volume":"22","author":"Minnis","year":"2018","journal-title":"AIDS Behav"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0156","doi-asserted-by":"crossref","first-page":"e25283","DOI":"10.1002\/jia2.25283","article-title":"End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study","volume":"22","author":"Montgomery","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"10.1016\/j.contraception.2021.10.001_bib0157","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","article-title":"Acceptability and use of a dapivirine vaginal ring in a phase III trial","volume":"31","author":"Montgomery","year":"2017","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.contraception.2021.10.001_bib0158","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/apc.2017.0075","article-title":"Favoring \u201cPeace of Mind\u201d: A qualitative study of African women's HIV prevention product formulation preferences from the MTN-020\/ASPIRE trial","volume":"31","author":"van der Straten","year":"2017","journal-title":"AIDS Patient Care STDs"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0159","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/QAI.0000000000002028","article-title":"First impressions matter: how initial worries influence adherence to the dapivirine vaginal ring","volume":"81","author":"van der Straten","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jadohealth.2007.12.007","article-title":"Adolescent experiences with the vaginal ring","volume":"43","author":"Epstein","year":"2008","journal-title":"J Adolesc Health"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0161","article-title":"Contraceptive vaginal ring experiences among women and men in Kisumu, Kenya: a qualitative study. Frontiers in Women's","volume":"2","author":"McLellan-Lemal","year":"2017","journal-title":"Health (N Y)"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0162","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jadohealth.2009.02.007","article-title":"Attitudes toward the vaginal ring and transdermal patch among adolescents and young women","volume":"45","author":"Raine","year":"2009","journal-title":"J Adolesc Health"},{"issue":"11","key":"10.1016\/j.contraception.2021.10.001_bib0163","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/QAD.0000000000001868","article-title":"Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results","volume":"32","author":"Montgomery","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2021.10.001_bib0164","series-title":"Virtual: International AIDS Society","article-title":"Adherence to the dapivirine vaginal ring and oral PrEP among adolescent girls and young women in Africa: interim results from the REACH study","author":"Nair","year":"2021"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-10-13","article-title":"Cross-cultural adaptation of research instruments: language, setting, time and statistical considerations","volume":"10","author":"Gjersing","year":"2010","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.contraception.2021.10.001_bib0166","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/bjhp.12295","article-title":"Acceptability of health care interventions: A theoretical framework and proposed research agenda","volume":"23","author":"Sekhon","year":"2018","journal-title":"Br. J. Health Psychol."},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0167","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijnurstu.2012.02.015","article-title":"A systematic survey instrument translation process for multi-country, comparative health workforce studies","volume":"50","author":"Squires","year":"2013","journal-title":"Int J Nurs Stud"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0168","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/AOG.0b013e3181d41c4a","article-title":"Association between tampon use and choosing the contraceptive vaginal ring","volume":"115","author":"Tepe","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0169","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/jurban\/78.4.571","article-title":"Female-initiated barrier methods for the prevention of STI\/HIV: where are we now? Where should we go?","volume":"78","author":"Latka","year":"2001","journal-title":"J Urban Health"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0170","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10461-012-0333-8","article-title":"Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women","volume":"17","author":"Minnis","year":"2013","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Ferti Steril"},{"key":"10.1016\/j.contraception.2021.10.001_bib0172","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/PPA.S24752","article-title":"A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence","volume":"6","author":"Barbosa","year":"2012","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"10.1016\/j.contraception.2021.10.001_bib0173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199096","article-title":"High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda","volume":"13","author":"Kestelyn","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.contraception.2021.10.001_bib0174","series-title":"Progesterone vaginal ring: Results of a three-country acceptability study","author":"RamaRao","year":"2015"},{"key":"10.1016\/j.contraception.2021.10.001_bib0175","doi-asserted-by":"crossref","unstructured":"Ishaku, Salisu Mohammed, Afolabi Kayode, Godwin Unumeri, Ayodeji Oginni, Adekunle Adeyemi, Deepa Rajamani, Heather Clark, Naomi Rijo, and Saumya RamaRao. 2015. Progesterone vaginal ring: Results of an acceptability study in Nigeria. New York: Population Council.","DOI":"10.31899\/rh9.1065"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0176","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000298338.58511.d1","article-title":"Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial","volume":"111","author":"Creinin","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.contraception.2021.10.001_bib0177","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2307\/1965397","article-title":"User's perception of the contraceptive vaginal ring: a field study in Brazil and the Dominican Republic","volume":"14","author":"Hardy","year":"1983","journal-title":"Stud Fam Plann"},{"issue":"1","key":"10.1016\/j.contraception.2021.10.001_bib0178","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0010-7824(94)00005-H","article-title":"The acceptability of a combined oestrogen\/progestogen contraceptive vaginal ring","volume":"51","author":"Weisberg","year":"1995","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.contraception.2021.10.001_bib0179","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0010-7824(97)00133-9","article-title":"Effect of different insertion regimens on side effects with a combination contraceptive vaginal ring","volume":"56","author":"Weisberg","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.10.001_bib0180","first-page":"E385","article-title":"Nurses and contraceptive vaginal ring: To use or not to use?","volume":"131","author":"Siraj","year":"2015","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0181","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13625187.2002.11949331","article-title":"Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing","volume":"7","author":"Roumen","year":"2002","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"2","key":"10.1016\/j.contraception.2021.10.001_bib0182","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0010-7824(91)90040-M","article-title":"The efficacy and acceptability of a low-dose levonorgestrel intravaginal ring for contraception in a UK cohort","volume":"43","author":"Elder","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.10.001_bib0183","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(19)30265-7","article-title":"Efficacy of the 1-year (13-cycle) segesterone acetate and ethinylestradiol contraceptive vaginal system: results of two multicentre, open-label, single-arm, phase 3 trials","author":"Archer","year":"2019","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.contraception.2021.10.001_bib0184","unstructured":"Ipsos H. Summary Booklet: Assessing the Potential of MPTs in South Africa, Uganda, and Nigeria. 2021"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0185","doi-asserted-by":"crossref","first-page":"e25283","DOI":"10.1002\/jia2.25283","article-title":"End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study","volume":"22","author":"Montgomery","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0186","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196904","article-title":"Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial","volume":"13","author":"Nel","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.contraception.2021.10.001_bib0187","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s10461-012-0248-4","article-title":"Vaginal ring adherence in sub-Saharan Africa: expulsion, removal, and perfect use","volume":"16","author":"Montgomery","year":"2012","journal-title":"AIDS Behav"},{"key":"10.1016\/j.contraception.2021.10.001_bib0188","article-title":"Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women","author":"Chen","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.contraception.2021.10.001_bib0189","first-page":"380","article-title":"Initial feasibility, acceptability and user experience of a multi-drug POD-IVR: A mixed methods study","volume":"32","author":"Guthrie","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"10.1016\/j.contraception.2021.10.001_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197269","article-title":"User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences","volume":"13","author":"Guthrie","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.contraception.2021.10.001_bib0191","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.contraception.2020.04.016","article-title":"Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India","volume":"102","author":"Roy","year":"2020","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421004108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421004108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:20:14Z","timestamp":1757881214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782421004108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":191,"alternative-id":["S0010782421004108"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2021.10.001","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}